SCHEMBL21037349

SCHEMBL21037349

c1ccc(-c2ccc(-c3ccc(N(c4ccccc4-c4ccc5c6ccccc6n(-c6ccccc6)c5c4)c4ccccc4-c4ccc5c6ccccc6n(-c6ccccc6)c5c4)cc3)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.46
KDM4E B2RXH2 2/20 0.46
ATM Q13315 1/20 0.46
METAP2 P50579 2/20 0.36
KMT2A Q03164 3/20 0.35
IL1R1 P14778 1/20 0.35
HDAC4 P56524 1/20 0.34
MAPT P10636 3/20 0.34
ALDH1A1 P00352 2/20 0.34
MEN1 O00255 2/20 0.34
HTT P42858 1/20 0.34
AVPR1A P37288 1/20 0.33
TSPO P30536 1/20 0.32
MAPK8 P45983 1/20 0.32
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
HSP90AA1 P07900 1/20 0.30
MAPK14 Q16539 1/20 0.30
MAT2A P31153 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17056487 0.97 L3MBTL1 (0.46) L3MBTL1KDM4EATMMETAP2KMT2A
SCHEMBL17056483 0.96 L3MBTL1 (0.45) L3MBTL1KDM4EATMMETAP2KMT2A
SCHEMBL17056519 0.95 KDM4E (0.44) L3MBTL1KDM4EATMMETAP2KMT2A
SCHEMBL17250258 0.94 L3MBTL1 (0.43) L3MBTL1KDM4EATMMETAP2KMT2A
SCHEMBL17056555 0.94 KDM4E (0.43) L3MBTL1KDM4EATMMETAP2KMT2A
SCHEMBL17056488 0.94 L3MBTL1 (0.41) L3MBTL1KDM4EATMMETAP2KMT2A
SCHEMBL17722270 0.94 L3MBTL1 (0.41) L3MBTL1KDM4EATMMETAP2KMT2A
SCHEMBL18365575 0.94 L3MBTL1 (0.45) L3MBTL1KDM4EATMMETAP2KMT2A
SCHEMBL17056498 0.93 L3MBTL1 (0.40) L3MBTL1KDM4EATMMETAP2KMT2A
SCHEMBL26539834 0.93 L3MBTL1 (0.40) L3MBTL1KDM4EATMMETAP2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11832513-B2 Materials for electronic devices MERCK PATENT GMBH (DE) 2023-11-28 US disclosed
US-11832513-B2 Materials for electronic devices MERCK PATENT GMBH (DE) 2023-11-28 US disclosed
EP-4242286-A2 MATERIALS FOR ELECTRONIC DEVICES Merck Patent GmbH (DE) 2023-09-13 EP disclosed
EP-3714022-B1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-06-07 EP disclosed
US-20200303654-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2020-09-24 US disclosed
WO-2019101719-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2019-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11832513-B2 Materials for electronic devices PNMT, DDT, COMT L3MBTL1 3148/4885KDM4E 3302/4885ATM 1537/4885
US-20200303654-A1 MATERIALS FOR ELECTRONIC DEVICES PNMT, DDT, COMT L3MBTL1 3148/4885KDM4E 3302/4885ATM 1537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.